Concepedia

AH Partridge

AP

Statistics

Publications

4

Citations

319

H-Index

4

Active since

2006

Affiliations

Dana-Farber Cancer Institute(Current)

Brigham and Women's Hospital

Dana-Farber Brigham Cancer Center

Harvard University

AH Partridge is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and chemotherapy.

Publications per year

2006–2018

4

Publications

4

Risk Perceptions and Psychosocial Outcomes of Women With Ductal Carcinoma In Situ: Longitudinal Results From a Cohort Study

AH Partridge, K. O. Adloff, Emily Blood et al. · JNCI Journal of the National Cancer Institute · 2008 · 174 citations · Full text

Medicine, Oncology, Surgery +17

Menopausal-type symptoms in young breast cancer survivors

M.G. Leining, Shari Gelber, R. Rosenberg et al. · Annals of Oncology · 2006 · 96 citations · Full text

Medicine, Gynecology, Oncology +14

Abstract S1-04: A phase II study of adjuvant paclitaxel (T) and trastuzumab (H) (APT trial) for node-negative, HER2-positive breast cancer (BC)

SM Tolaney, WT Barry, CT Dang et al. · Cancer Research · 2013 · 36 citations

Medicine, Oncology, Pharmacology +17

Abstract GS4-01: Pooled analysis of five randomized trials investigating temporary ovarian suppression with gonadotropin-releasing hormone analogs during chemotherapy as a strategy to preserve ovarian function and fertility in premenopausal early breast cancer patients

Matteo Lambertini, HCF Moore, RCF Leonard et al. · Cancer Research · 2018 · 13 citations

Medicine, Endocrinology, Oncology +15

1–4 of 4